REGENERON PHARMACEUTICALS's ticker is and the CUSIP is 75886F907. A total of 7 filers reported holding REGENERON PHARMACEUTICALS in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $26,252,424 | -70.9% | 31,900 | -74.6% | 0.09% | -69.7% |
Q2 2023 | $90,248,624 | -7.2% | 125,600 | +6.1% | 0.29% | -17.4% |
Q1 2023 | $97,285,728 | +68.3% | 118,400 | +47.8% | 0.35% | +161.9% |
Q4 2022 | $57,791,349 | +31.5% | 80,100 | +25.5% | 0.13% | +55.8% |
Q3 2022 | $43,950,000 | +31.6% | 63,800 | +12.9% | 0.09% | +65.4% |
Q2 2022 | $33,399,000 | -16.1% | 56,500 | -0.9% | 0.05% | +33.3% |
Q1 2022 | $39,810,000 | -52.0% | 57,000 | -56.6% | 0.04% | -41.8% |
Q4 2021 | $82,855,000 | +4.2% | 131,200 | -0.2% | 0.07% | -22.1% |
Q3 2021 | $79,521,000 | +31.6% | 131,400 | +21.4% | 0.09% | +17.8% |
Q2 2021 | $60,434,000 | +25.5% | 108,200 | +6.3% | 0.07% | +2.8% |
Q1 2021 | $48,166,000 | +15.3% | 101,800 | +17.7% | 0.07% | -1.4% |
Q4 2020 | $41,789,000 | +661.7% | 86,500 | +782.7% | 0.07% | +323.5% |
Q3 2020 | $5,486,000 | -24.8% | 9,800 | -16.2% | 0.02% | -50.0% |
Q2 2020 | $7,297,000 | +293.2% | 11,700 | +207.9% | 0.03% | +126.7% |
Q1 2020 | $1,856,000 | – | 3,800 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Garda Capital Partners LP | 3,500 | $2,880,360 | 0.13% |
GROUP ONE TRADING, L.P. | 31,900 | $26,252,424 | 0.09% |
SIMPLEX TRADING, LLC | 33,500 | $27,569 | 0.02% |
IMC-Chicago, LLC | 26,500 | $21,808,440 | 0.02% |
Allianz Asset Management GmbH | 12,400 | $10,204,704 | 0.02% |
SG Americas Securities, LLC | 16,700 | $1,142 | 0.01% |
JANE STREET GROUP, LLC | 42,400 | $34,893,504 | 0.01% |
JPMORGAN CHASE & CO | 32,900 | $27,075,384 | 0.00% |
Focused Wealth Management, Inc | 400 | $12,441 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |